Other / Other / MRI

Endolymphatic sac tumor

Endolymphatic sac tumors are rare, locally aggressive tumors typically presenting in young adults (mean age 22 years) with hearing loss (95%), tinnitus (92%), and vertigo/disequilibrium (62%), often associated with von Hippel-Lindau disease.
Look For First
  • Lesion centered in the vestibular aqueduct and posterior petrous bone with infiltrative/moth-eaten bone erosion on CT
  • T1 hyperintense foci with heterogeneous enhancement on MRI, suggesting internal hemorrhage or high protein content
  • Association with von Hippel-Lindau disease presentation or bilateral tumors in that context
Key Image Findings
  • On CT: infiltrative or moth-eaten pattern of petrous bone erosion centered in the vestibular aqueduct, with central calcific spiculation and posterior rim calcification, often showing intense enhancement.
  • On MRI T1: most tumors display foci of hyperintensity, indicating blood products or high protein content within the lesion.
  • On MRI T2: heterogeneous signal intensity throughout the lesion, reflecting mixed solid and potentially hemorrhagic components.
  • On MRI post-gadolinium: heterogeneous enhancement specifically involving the non-cystic component of the tumor, which helps distinguish tumor tissue from cystic/fluid portions.
  • Location is pathognomonic—lesion always arises within the vestibular aqueduct, involving the endolymphatic sac or duct, with disease centered in the retrolabyrinthine (posterior) petrous bone.
  • Histological type influences imaging appearance: papillary adenomatous type (more aggressive) shows greater local bone invasion compared to mixed type (generally confined).
Differential Diagnosis
  • Jugular paraganglioma: center of lesion located at the jugular bulb rather than the vestibular aqueduct, and typically shows different vascular flow voids.
  • Enlarged vestibular aqueduct: smooth-margined dilatation of the aqueduct maintaining normal shape, without infiltrative bone erosion or enhancement.
  • Petrous apicitis: located within petrous air cells rather than centered on the vestibular aqueduct, with bone around aqueduct typically not aerated.
  • Cholesterol granuloma: most often arises in the petrous apex rather than the vestibular aqueduct, and shows characteristic T1 hyperintensity without bone erosion.
  • Meningioma: typically shows hyperostotic thickening of underlying bone rather than infiltrative moth-eaten erosion.
  • Bony metastasis: different clinical context and does not characteristically center on the vestibular aqueduct.
Discussion

Endolymphatic sac tumors do not metastasize but are highly locally aggressive, making early detection critical to prevent further hearing loss through timely surgical intervention.

Von Hippel-Lindau disease is the most common association, present in 11-16% of VHL patients; bilateral tumors occur in 30% of VHL-associated cases, necessitating careful bilateral temporal bone imaging.

The pathological type influences aggressiveness: papillary adenomatous type is more invasive and locally destructive, while mixed type is generally more confined and may show less prominent bone erosion.

The characteristic location within the vestibular aqueduct and retrolabyrinthine petrous bone is a key distinguishing feature that should guide differential diagnosis and imaging interpretation.

Clinical presentation of gradual or acute hearing loss combined with tinnitus and vertigo should raise suspicion for endolymphatic sac tumor, particularly in younger patients.

Early surgical excision is the treatment of choice, making prompt radiological diagnosis and characterization essential for patient outcomes and timing of intervention.

Reporting Pearls

Report the location precisely as centered on the vestibular aqueduct in the posterior petrous bone, describe the pattern of bone erosion as infiltrative or moth-eaten (rather than smooth expansion), note the presence of calcification and hemorrhagic signal on MRI (T1 hyperintensity), and recommend correlation with clinical symptoms and Von Hippel-Lindau disease status; bilateral imaging assessment is mandatory for complete characterization.

Pitfalls
  • Confusing enlarged vestibular aqueduct with endolymphatic sac tumor—enlarged aqueducts have smooth, normal-shaped margins without infiltrative bone erosion or enhancement.
  • Misinterpreting the T1 hyperintensity as fat or high protein content from other sources (cholesterol granuloma, petrous apicitis) rather than recognizing the characteristic enhancement of the non-cystic tumor component.
  • Failing to assess for bilateral disease in patients with known or suspected von Hippel-Lindau disease, where 30% of tumors are bilateral.
  • Missing the diagnosis by not recognizing the specific location within the vestibular aqueduct and posterior petrous bone; lesions elsewhere (jugular bulb, petrous apex) should prompt alternative diagnoses.